Abstracts tagged "tumor and differential diagnosis"

Abstract Number: 2725 • 2019 ACR/ARP Annual Meeting
Clinical Factors Distinguishing Between Pediatric Tumors with Arthritis at Onset and JIA: Preliminary Analysis of the ONCOREUM Study
Adele Civino¹, Gianni Alighieri ², Roberto Rondelli ³, Silvia Magni-Manzoni ⁴, Micol Romano ⁵, Giovanni Filocamo ⁶, Francesca Santarelli ⁷, Francesca Ricci ⁸, Alma Nunzia Olivieri ⁹, Serena Pastore ¹⁰, Patrizia Barone ¹¹, Romina Gallizzi ¹², Angela Miniaci ¹³, Manuela Marsili ¹⁴, Rosanna Podda ¹⁵, Bianca Lattanzi ¹⁶, Maria Cristina Maggio ¹⁷, Rita Consolini ¹⁸, Francesco La Torre ¹⁹, Maria Antonietta Pelagatti ²⁰, Francesca Soscia ²¹, Alessandro De Fanti ²², Donato Rigante ²³, Eleonora Prete ²⁴, Giulia Stabile ²⁵, Andrea Roncadori ²⁶, Loredana Lepore ²⁷, Valentino Conter ²⁸, Andrea Pession ²⁹ and Angelo Ravelli ³⁰, ¹Pediatric Rheumatology “Vito Fazzi” Hospital, Lecce, Lecce, Italy, ²Pediatric Unit “Card. G. Panico” Hospital, Tricase, Tricase, Italy, ³Department of Pediatrics, "Lalla Seragnoli" , Hematology - Oncology Unit , University of Bologna, Bologna, ⁴Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Roma, ⁵Division of Rheumatology, ASST Gaetano Pini, Milan, Milano, ⁶Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Milano, Italy, ⁷Pediatric Immunology and Rheumatology, "Regina Margherita" Children Hospital, University of Turin, Torino, Italy, ⁸Pediatric Clinic, Asst Spedali Civili, University of Brescia, Brescia, Italy, ⁹Pediatric Rheumatology, Second University of Studies of Naples, Napoli, Italy, ¹⁰Pediatric Rheumatology, IRCCS Burlo Garofolo, Trieste, Italy;, Trieste, Italy, ¹¹Department of Pediatrics, University of Catania, Catania, Italy, Catania, Italy, ¹²Azienda Ospedaliera Universitaria Gaetano Martino, Messina, Messina, Italy, ¹³Department of Pediatrics, "Lalla Seragnoli" , Rheumatology , University of Bologna, Bologna, Italy, ¹⁴Pediatric Rheumatology, University of Chieti, Chieti, Italy, ¹⁵Paediatric Rheumatology, Ospedale Pediatrico Microcitemico A. Cao, Cagliari, Cagliari, Italy, ¹⁶Pediatric Rheumatology, Ospedali Riuniti di Ancona, Ancona, Italy, ¹⁷Department of Health Promotion Sciences Maternal and Infantile Care, “G. D’Alessandro”, University of Palermo, Palermo, Italy, ¹⁸Department of clinical and experimental Medicine University of Pisa, Pisa, Italy, ¹⁹Rheumatology Section. Pediatric Unit. Giovanni XXIII Pediatric Hospital. Bari, Bari, Italy, ²⁰Paediatric Rheumatology, MBBM Foundation, San Gerardo Hospital Monza, Monza, Italy, ²¹Pediatric Unit Santa Maria della Stella Hospital, Orvieto, Orvieto, Italy, ²²Pediatric and Adolescent Rheumatology Unit Azienda USL-IRCCS, Reggio Emilia, Reggio Emilia, Italy, ²³Institute of Pediatrics, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, Roma, Italy, ²⁴Department of Hematology and Bone Marrow Trasplant Card. G. Panico” Hospital, Tricase, Tricase, Italy, ²⁵Inter-University Consortium Cineca, Casalecchio di Reno (BO), Casalecchio di Reno, ²⁶Inter-University Consortium Cineca, Casalecchio di Reno (BO), Casalecchio di Reno, Italy, ²⁷Pediatric Rheumatology, IRCCS Burlo Garofolo, Trieste, Trieste, Italy, ²⁸Paediatric Haemato-Oncology, University of Milano-Bicocca, MBBM Foundation, Monza, Monza, Italy, ²⁹Department of Pediatrics, "Lalla Seragnoli" , Hematology - Oncology Unit , University of Bologna, Bologna, Italy, ³⁰Pediatric Rheumatology, IRCCS Giannina Gaslini Institute Genova, Genova, Italy
Background/Purpose: Musculoskeletal (MSK) symptoms are a common presenting complaint in pediatric primary care (estimated prevalence 25-50%) and may be the initial manifestation of cancer in…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].